Expanding Hemoglobin Conjugates: Novel Applications and Use Cases

The present inventive concept leverages the core technology of thiosuccinyl-crosslinked hemoglobin conjugates to address unmet needs in diverse industries, including athletic performance, environmental remediation, cancer diagnostics, agriculture, and industrial wastewater treatment.

The original patent disclosed thiosuccinyl-crosslinked hemoglobin conjugates for repeated doses or prolonged exposure in pharmaceutical applications. However, the full potential of this technology remains untapped in other fields. The present inventive concept addresses this limitation by exploring new applications and use cases that were not originally considered.

The newly generated claims introduce novel applications of thiosuccinyl-crosslinked hemoglobin conjugates. For instance, Claim 1 describes a system for improving athletic performance by administering the conjugate to enhance endurance. Claim 2 outlines a method for reducing environmental pollutants by using the conjugates to absorb and break down toxic chemicals. Similarly, Claims 3-5 detail the use of these conjugates in cancer diagnostics, agricultural yield enhancement, and industrial wastewater treatment, respectively. These new applications capitalize on the unique properties of thiosuccinyl-crosslinked hemoglobin conjugates, such as their ability to bind to specific targets and facilitate biochemical reactions.

The novelty of the present inventive concept lies in the unexpected application of thiosuccinyl-crosslinked hemoglobin conjugates to unrelated fields, thereby creating new opportunities for innovation and problem-solving. The inventive step resides in the identification of these new use cases and the development of corresponding systems and methods.

Alternative embodiments of the inventive concept could include the use of different polymer types, linker chemistries, or crosslinking moieties to tailor the conjugates for specific applications. Additionally, the conjugates could be modified to target specific cell types or tissues, further expanding their potential uses.

The present inventive concept has significant commercial potential across multiple industries, including sports medicine, environmental remediation, cancer diagnostics, agriculture, and industrial wastewater treatment. The market size for these applications is substantial, and the inventive concept offers a unique value proposition by leveraging the established technology of thiosuccinyl-crosslinked hemoglobin conjugates.